Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
-
* Corresponding author: Ellen R Copson erc1@soton.ac.uk
BMC Cancer 2006, 6:80 doi:10.1186/1471-2407-6-80
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 24 Nov 2005 | |
| Reviewer's Report | Petr Pohlreich | 17 Dec 2005 | |
| Reviewer's Report | Jeff Struewing | 21 Dec 2005 | |
| Reviewer's Report | Pia Vahteristo | 23 Dec 2005 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 16 Jan 2006 |
| Reviewer's Report | Pia Vahteristo | 09 Feb 2006 | |
| Reviewer's Report | Jeff Struewing | 14 Feb 2006 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 28 Feb 2006 |
| Resubmission - Version 4 | 07 Mar 2006 | ||
| Resubmission - Version 5 | Manuscript | Author's comment | 07 Mar 2006 |
| Published | 24 Mar 2006 |